EUVIMEDEUVIMED entdecken
Crossref

Patient Characteristics Across Lipoprotein(a) Levels: Insights From a Retrospective Study

Clara M Howell, Liv Hald Nyhave, Bent Raungaard, Aase Handberg, Claus Gyrup Nielsen, Christian Bork, Stine Krogh Venø iD

Lipids · 2025

DOI: 10.1002/lipd.70025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lipids, 2025. Verfasst von Clara M Howell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Lipoprotein(a), Atherosclerosis. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated plasma lipoprotein(a) (Lp(a)) (> 125 nmol/L) is highly prevalent and a causal risk factor for atherosclerotic cardiovascular disease (ASCVD) that may contribute significantly to plasma levels of low‐density lipoprotein‐cholesterol (LDL‐C). This study aimed to describe clinical characteristics across Lp(a) levels and to estimate the proportion of individuals with normal, moderately elevated, or elevated LDL‐C earlier in life according to levels of Lp(a), to assess whether LDL‐C levels are a reliable marker for an underlying elevated Lp(a) level. In this retrospective study, detailed information on clinical characteristics was collected through medical records, while biochemical data was retrieved from the North Denmark Region Clinical Laboratory System (LABKA) I and II between January 2021 and August 2024. A total of 1346 individuals were included of whom 28.5% had elevated Lp(a) levels ≥ 125 nmol/L. A history of ASCVD was found in 57.7% of patients with Lp(a) levels ≥ 400 nmol/L compared to 21.1% of patients with Lp(a) levels < 100 nmol/L and the median age of onset of ASCVD was 51 years and 56 years, respectively. Furthermore, in individuals with Lp(a) levels ≥ 300 nmol/L, we found that 7.6% had LDL‐C < 3.0 mmol/L and 9.1% had LDL‐C between 3.0 and 3.5 mmol/L when measured for the first time, respectively. This study highlights distinct clinical characteristics across Lp(a) levels. With increasing Lp(a) levels, the prevalence of ASCVD increased, while the age at onset of ASCVD decreased. Furthermore, we found that LDL‐C within the normal range cannot be used to rule out highly elevated Lp(a) levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)AtherosclerosisHumansMiddle AgedRetrospective StudiesMaleFemaleCholesterol, LDLAdultAgedDenmarkRisk FactorsBiomarkers

Stichwörter der Autor:innen

cardiovascular diseasefamilial hypercholesterolemialipid cliniclipoprotein(a)low‐density lipoprotein‐cholesterol

Substanzen

Lipoprotein(a)Cholesterol, LDLBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.

ORCID-Profile: Stine Krogh Venø

Zitieren

APA

Howell, C. M., Hald Nyhave, L., Raungaard, B., Handberg, A., Nielsen, C. G., Bork, C., & Venø, S. K. (2025). Patient Characteristics Across Lipoprotein(a) Levels: Insights From a Retrospective Study. Lipids. https://doi.org/10.1002/lipd.70025

Vancouver

Howell CM, Hald Nyhave L, Raungaard B, Handberg A, Nielsen CG, Bork C, et al. Patient Characteristics Across Lipoprotein(a) Levels: Insights From a Retrospective Study. Lipids. 2025. doi:10.1002/lipd.70025

BibTeX
@article{Howell2025,
  author = {Howell, Clara M and Hald Nyhave, Liv and Raungaard, Bent and Handberg, Aase and Nielsen, Claus Gyrup and Bork, Christian and Venø, Stine Krogh},
  title = {Patient Characteristics Across Lipoprotein(a) Levels: Insights From a Retrospective Study},
  journal = {Lipids},
  year = {2025},
  doi = {10.1002/lipd.70025}
}
Kostenlos starten →